BANK OF MONTREAL /CAN/ - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 14 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,002,000
+142.6%
4,517,000
+201.1%
0.00%0.0%
Q2 2020$2,062,0001,500,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 16,000,000$16,661,0001.26%
Opti Capital Management, LP 9,000,000$9,367,0001.14%
Context Capital Management, LLC 10,500$10,883,0001.07%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 20,000,000$20,429,0000.20%
AQR Arbitrage LLC 4,100,000$4,249,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 25,000,000$25,538,0000.13%
CAPSTONE INVESTMENT ADVISORS, LLC 13,500,000$13,992,0000.04%
LAZARD ASSET MANAGEMENT LLC 22,500,000$23,319,0000.03%
Citadel Advisors 48,300,000$50,405,0000.01%
MACKAY SHIELDS LLC 93,000$96,0000.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders